JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 19 No. 9 985-993
© 1978 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, W.-N. P.
Right arrow Articles by Kaplan, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, W.-N. P.
Right arrow Articles by Kaplan, S. A.

Use of I-123 in Early Radioiodide Uptake and Its Suppression in Children and Adolescents with Hyperthyroidism

Wai-Nang P. Lee, Pantelis D. Mpanias, Rodney J. Wimmer, Moses A. Greenfield and Solomon A. Kaplan

UCLA School of Medicine, Los Angeles, California

Correspondence: For reprints contact: Wai-Nang P. Lee, Div. of Endocrinology, Dept. of Pediatrics, UCLA School of Medicine, Los Angeles, CA 90024.

ABSTRACT

Absolute activity measurement of I-123 by coincidence counting was used to study the early thyroidal iodide uptake in 20 hyperthyroid children. Patients were pretreated either with methimazole or propylthiouracil before injection of Na123I. The usual method of analysis of the early uptake was modified to account for a rapidly equilibrating compartment, to give thyroidal iodide trapping rate constant (K1) and absolute iodide uptake (AIU).

The suppressibility of the early uptake by triiodothyronine (T3) was evaluated in some patients. The upper limit of normal for K1 was 0.03 min–1 and for AIU was 0.04 µg/min. In the hyperthyroid subjects, K1 and AIU were in the hyperthyroid range before and after T3 suppression. For patients with suppressible uptake, remission from hyperthyroidism was maintained for 6 mo to 21/2 yr. Only two patients with nonsuppressible uptake achieved remission from hyperthyroidism, perhaps because of coexistence of thyroiditis.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1978 by the Society of Nuclear Medicine.